20 results on '"Starý J"'
Search Results
2. HEMATOPOIETIC STEM CELL TRANSPLANTATION FOLLOWING CONDITIONING WITH BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN IN CHILDREN WITH THERAPY RELATED MYELODYSPLASTIC SYNDROME: PH-P589
3. Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report
4. Signature profiles of CMV-specific T-cells in patients with CMV reactivation after hematopoietic SCT
5. Immunosuppressive therapy with anti-thymocyte globin and cyclosporine A in patients with refractory cytopenia in childhood: P1166
6. Stem cell transplantation for therapy-related myelodysplastic syndrome following treatment for childhood acute lymphoblastic leukaemia: O168
7. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study
8. Myelodysplastic syndromes in adolescents: characteristics and clinical outcome: O302
9. Haematopoietic stem cell transplantation for advanced primary myelodysplastic syndromes in children: influence of chromosomal aberrations on outcome: O265
10. Haematopoietic stem cell transplantation for advanced primary MDS in children: results of the EWOG MDS study group
11. Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia
12. Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia
13. JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia
14. Low mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulin
15. Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy
16. Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia
17. Allogenic stem cell transplantation for children with advanced MDS: results from the EWOG-MDS study group employing a pre-transplant preparative regimen with busulfan, cyclophosphamide and melphalan
18. Stem cell transplantation for aplastic anemia and myelodysplastic syndrome
19. The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML)
20. EXPRESSION OF CYTOKINE RECEPTORS ON NEOPLASTIC CELL TYPES OF PATIENTS WITH LEUKAEMIAS/LYMPHOMAS: CR-4-08
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.